Centre approves Corbevax as precaution dose

Centre


New Delhi, Aug 10 : The Centre on Wednesday approved Biological E's Corbevax as a heterologous precaution dose for adults above 18 years for restricted use with two doses of either Covishield or Covaxin, said a source. According to the source, the Corbevax vaccine will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines. Meanwhile, India on Wednesday reported 16,047 new Covid-19 cases in the last 24 hours. In the same period, there were 54 additional deaths, taking the nationwide death toll to 5,26,826. /IANS




Related

India reports 5,108 new Covid cases, 31 deaths
New Delhi, Sep 14 : In the last 24 hours, India reported 5,108 new Covid-19 cases and 31 deaths, the Union Health Ministry said on Wednesday. Th

SP MLA gives Rs 21 lakh for child suffering from SMA
Lucknow, Sep 14 : In a heart-warming gesture, Rakesh Pratap Singh, Samajwadi Party MLA from Gauriganj in Amethi, has given Rs 21 lakh for the treatmen

UP campaign against communicable diseases
Lucknow, Sep 14 : The Uttar Pradesh government will be launching a state-wide campaign against communicable diseases from October 1 which will last fo